UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Arcutis Biotherapeutics
ARQT
$3.18B
| $2.55M | ﹤0.01% |
+273,779
| New | +$2.48M |
|
1852
Utz Brands
UTZ
$1.25B
| $2.54M | ﹤0.01% |
152,944
+42,815
| +39% | +$771K |
|
1853
Rocket Pharmaceuticals
RCKT
$394M
| $2.54M | ﹤0.01% |
118,072
+52,282
| +79% | +$1.2M |
|
1854
Trupanion
TRUP
$1.18B
| $2.54M | ﹤0.01% |
86,443
+44,045
| +104% | +$1.17M |
|
1855
National Vision
EYE
$1.81B
| $2.54M | ﹤0.01% |
194,010
+67,855
| +54% | +$1.11M |
|
1856
Indivior Pharmaceuticals
INDV
$4.58B
| $2.53M | ﹤0.01% |
+157,094
| New | +$2.84M |
|
1857
Innoviva
INVA
$1.48B
| $2.53M | ﹤0.01% |
154,410
+109,366
| +243% | +$1.7M |
|
1858
Liberty Broadband Class A
LBRDA
$5.16B
| $2.53M | ﹤0.01% |
46,284
+21,778
| +89% | +$1.13M |
|
|
VSXY
1859
Victoria's Secret
VSXY
$7.83B
| $2.52M | ﹤0.01% |
142,782
+21,596
| +18% | +$411K |
|
|
SIX
1860
DELISTED
Six Flags Entertainment Corp.
SIX
| $2.52M | ﹤0.01% |
76,106
-13,491
| -15% | -$355K |
|
1861
N-able
NABL
$940M
| $2.51M | ﹤0.01% |
164,752
+95,155
| +137% | +$1.25M |
|
1862
Winmark
WINA
$1.32B
| $2.51M | ﹤0.01% |
7,111
+4,507
| +173% | +$1.61M |
|
1863
Helen of Troy
HELE
$693M
| $2.48M | ﹤0.01% |
26,723
-8,377
| -24% | -$849K |
|
1864
Hawaiian Electric Industries
HE
$2.14B
| $2.48M | ﹤0.01% |
274,707
-68,164
| -20% | -$708K |
|
1865
Supernus Pharmaceuticals
SUPN
$2.77B
| $2.48M | ﹤0.01% |
92,539
+41,172
| +80% | +$1.19M |
|
1866
ChargePoint
CHPT
$161M
| $2.47M | ﹤0.01% |
81,647
+58,870
| +258% | +$1.92M |
|
|
SCS
1867
DELISTED
Steelcase
SCS
| $2.46M | ﹤0.01% |
190,104
+84,562
| +80% | +$1.08M |
|
1868
HCI Group
HCI
$2.41B
| $2.46M | ﹤0.01% |
26,730
+8,472
| +46% | +$883K |
|
1869
Enact Holdings
ACT
$6.73B
| $2.46M | ﹤0.01% |
80,328
+43,462
| +118% | +$1.32M |
|
1870
Appian
APPN
$2.48B
| $2.46M | ﹤0.01% |
79,751
+34,047
| +74% | +$1.12M |
|
1871
Cushman & Wakefield Ltd
CWK
$3.25B
| $2.46M | ﹤0.01% |
236,600
+32,653
| +16% | +$338K |
|
|
LADR
1872
Ladder Capital
LADR
$1.24B
| $2.46M | ﹤0.01% |
217,570
+105,624
| +94% | +$1.16M |
|
1873
Ameresco
AMRC
$1.36B
| $2.46M | ﹤0.01% |
85,231
+32,188
| +61% | +$888K |
|
1874
Diamondrock Hospitality Co
DRH
$2.56B
| $2.45M | ﹤0.01% |
289,655
-804,399
| -74% | -$7M |
|
|
TGI
1875
DELISTED
Triumph Group
TGI
| $2.45M | ﹤0.01% |
158,778
+106,598
| +204% | +$1.52M |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.